比伐卢定用于肝素诱导的血小板减少症患者经皮冠状动脉介入治疗 - Suppr

Suppr

超能文献

Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.

作者信息

Campbell K R, Mahaffey K W, Lewis B E, Weitz J I, Berkowitz S D, Ohman E M, Califf R M

机构信息

Duke Clinical Research Institute, P.O. Box 17969, Durham, NC 27715, USA.

出版信息

J Invasive Cardiol. 2000 Dec;12 Suppl F:14F-9.

PMID:11156729

Abstract

摘要

相似文献

Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.

J Invasive Cardiol. 2000 Dec;12 Suppl F:14F-9.

Cost analysis of bivalirudin in percutaneous coronary intervention.

J Invasive Cardiol. 2000 Dec;12 Suppl F:37F-40.

Bivalirudin, a bivalent, thrombin specific anticoagulant as an alternative to heparin in interventional procedures as an alternative to heparin in interventional procedures.

Hamostaseologie. 2002 Aug;22(3):60-6.

Use of bivalirudin instead of heparin during a percutaneous coronary intervention in a patient with severe thrombocytopenia.

J Invasive Cardiol. 2004 Sep;16(9):535-6.

Bivalirudin: a direct thrombin inhibitor.

Clin Ther. 2002 Jan;24(1):38-58. doi: 10.1016/s0149-2918(02)85004-4.

Building a stronger foundation: improved antithrombin therapy with bivalirudin in percutaneous coronary intervention.

J Invasive Cardiol. 2002 Apr;14 Suppl B:1B.

Successful treatment of heparin-associated thrombocytopenia and thrombosis using Hirulog.

Can J Cardiol. 1995 Jun;11(6):511-4.

The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results.

J Invasive Cardiol. 2003 Nov;15(11):611-6.

A randomized comparison of bivalirudin and heparin in patients undergoing coronary angioplasty for postinfarction angina. Hirulog Angioplasty Study Investigators.

Am J Cardiol. 1998 Oct 22;82(8B):43P-49P. doi: 10.1016/s0002-9149(98)00766-8.

Clinical pharmacology of bivalirudin.

Pharmacotherapy. 2002 Jun;22(6 Pt 2):105S-111S. doi: 10.1592/phco.22.10.105s.33616.

引用本文的文献

Elucidation of Cellular Contributions to Heparin-Induced Thrombocytopenia Using Omic Approaches.

Front Pharmacol. 2022 Jan 21;12:812830. doi: 10.3389/fphar.2021.812830. eCollection 2021.

Evaluation of a rapid and automated heparin-induced thrombocytopenia immunoassay.

Int J Lab Hematol. 2019 Aug;41(4):478-484. doi: 10.1111/ijlh.13029. Epub 2019 Apr 15.

Novel oral anticoagulants for heparin-induced thrombocytopenia.

J Thromb Thrombolysis. 2016 Aug;42(2):172-8. doi: 10.1007/s11239-016-1365-0.

Risks and complications of coronary angiography: a comprehensive review.

Glob J Health Sci. 2012 Jan 1;4(1):65-93. doi: 10.5539/gjhs.v4n1p65.

Percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.

Curr Cardiol Rep. 2007 Sep;9(5):396-405. doi: 10.1007/BF02938367.

Heparin induced thrombocytopenia: diagnosis and management update.

Postgrad Med J. 2007 Sep;83(983):575-82. doi: 10.1136/pgmj.2007.059188.

Severe heparin-induced thrombocytopenia: when the obvious is not obvious, a case report.

J Med Case Rep. 2007 Apr 30;1:13. doi: 10.1186/1752-1947-1-13.

Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committee.

J Thromb Thrombolysis. 2005 Feb;19(1):11-9. doi: 10.1007/s11239-005-0850-7.

Anticoagulation for acute coronary syndromes and percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.

Curr Cardiol Rep. 2001 Sep;3(5):362-70. doi: 10.1007/s11886-001-0052-7.

Bivalirudin for percutaneous coronary intervention and in acute coronary syndromes.

Curr Cardiol Rep. 2001 Sep;3(5):348-54. doi: 10.1007/s11886-001-0050-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验